2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: A report of the American College of Cardiology Solution Set Oversight Committee

Authors

Salim S. Virani, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, USA.Follow
Pamela B. Morris, Medical University of South Carolina, USA.
Anandita Agarwala, Baylor Scott and White Health, USA.
Christie M. Ballantyne, Baylor College of Medicine and Methodist Hospital, USA.
Kim K. Birtcher, University of Houston College of Pharmacy, USA.
Penny M. Kris-Etherton, Pennsylvania State University, USA.
Amanda B. Ladden-Stirling, American College of Cardiology, USA.
Michael Miller, University of Maryland Medical Center, USA.
Carl E. Orringer, University of Miami Miller School of Medicine, USA.
Neil J. Stone, University of Miami Miller School of Medicine, USA.

Document Type

Article

Department

Cardiology; Office of the Provost

Comments

Abstract are not provided by the author/publisher. This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Journal of the American College of Cardiology

DOI

10.1016/j.jacc.2021.06.011

Recommended Citation

Virani, S. S., Morris, P. B., Agarwala, A., Ballantyne, C. M., Birtcher, K. K., Kris-Etherton, P. M., Ladden-Stirling, A. B., Miller, M., Orringer, C. E., Stone, N. J. (2021). 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: A report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology, 78(9), 960-993.
Available at: https://ecommons.aku.edu/provost_office/554